INVESTOR NEWS

Nov 29, 2021

Share Issue in Connection with Employee Share Purchase Program

Moss, 29 November 2021 Reference is made to the annual general meeting held on 4 May 2021 where a resolution..

Nov 03, 2021

Multicenter study confirms calprotectin’s role in risk stratification in COVID-19

Moss, 3 November 2021   Gentian Diagnostics ASA is pleased to announce that the results from the multicenter..

Nov 01, 2021

New study supports the value of calprotectin in management of COVID-19 patients

Moss, 1 November 2021   Gentian Diagnostics ASA is pleased to announce that the results from a study..

Oct 21, 2021

Third quarter 2021 report

Moss, 21 October 2021: Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..

Oct 12, 2021

Flaggemelding

Obligasjon 2 AS har 5. oktober 2021 kjøpt 85 000 aksjer i Gentian Diagnostics ASA til gjennomsnittlig pris..

Oct 05, 2021

Invitation to presentation of third quarter results

Gentian Diagnostics ASA will present its 2021 third quarter results on October 21st at 10.00 am. The..

Sep 08, 2021

Norron Sicav Flagging i Gentian Diagnostics ASA

Norron AB er forvalter for Norron Sicav. Norron Sicav, gjennom Norron Target, har idag, 8. September solgt..

Aug 26, 2021

Flaggemelding, Salix AS - Gentian Diagnostics ASA

Salix AS har 25. august 2021 solgt 10481 aksjer i Gentian Diagnostics ASA til gjennomsnittlig pris 66,12kr...

Aug 25, 2021

Mandatory notification of trade and disclosure of large shareholding

Vatne Equity AS, a closely related party of Runar Vatne, Board Member of Gentian Diagnostics ASA, has today..